Additionally, SOX9 contributes to the maintenance of GSC-like properties in GBM by activating pyruvate dehydrogenase kinase 1 (PDK1) via the PI3K-AKT pathway, a downstream target of SOX9 [15]. The gene discussed is SOX9; the disease is glioblastoma.